ACL · Australian Clinical Labs Ltd
2.91
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$522.25M
PE
18.10
EV/EBITDA
3.8
DIV Yield
5.8%
Franking
100%
MQV Rating
1Very Strong
As at 12/10/2026 04:10:18 PM
Price Chart
Description
- All-Companies
- All-Consensus
- GROWTH AUS
- HALO Capital Efficiency
- HALO Momentum
- HALO MQV
- HALO Ords
- HALO Price Momentum
Key Fundamentals
EPS 3 yr Growth
-30.90%
EBITDA Margin
27.00%
Operating Cashflow
$163m
Free Cash Flow Return
44.60%
ROIC
6.50%
Interest Coverage
10.70
Quick Ratio
0.50
Performance
52 weeks range
Low 1.83 - 3.03
Trade Value (12mth)
AU$419,248.00
1 week
5.38%
1 month
7.69%
YTD
7.69%
1 year
19.51%
All time high
6.39
Additional Data
Shares Outstanding (Fully Diluted)
192m
HALO Sector
Healthcare
Next Company Report Date
23-Aug-27
Next Ex Dividend Date
02-Sep-26
Next Dividend Pay Date
23-Sep-26
Reporting Currency
AUD
Short Sell (% of issue)
4.39
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Strong
Garp
Strong
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Strong
Growth
Earnings
Neutral
Dividends
Neutral
Quality
Capital Efficiency
Very Strong
Balance Sheet
Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
12 October 26ASXD | |
12 October 26ASXD | |
09 October 26ASXD | |
02 October 26ASXD | |
22 September 26ASXD |
Key Stakeholders
| Name | Title |
| Kohlberg Kravis Roberts & Co. LP | Subsidiary |
| United Super Pty Ltd. | Private Company |
| Melinda McGrath | Individual |
| Zachary Investments Pty Ltd. | Private Company |
| Anthony Friedli | Individual |
